Processing...
Processing...
Inmagic
®
Presto
Version 5.5 Build 151
Inmagic
®
Presto
Copyright © 2005-2021 by Lucidea Technologies Corp., Richmond BC Canada. All rights reserved.
Inmagic® and the Inmagic logo are registered trademarks of Lucidea Technologies Corp.
Unauthorized duplication or distribution is prohibited.
Other brand and product names are trademarks or registered trademarks of their respective holders. Use of any other product name does not imply endorsement of that product by Inmagic.
Third-party Licenses
Processing...
Processing...
Title
Risperidone and Autism
Author
Research Autism
Summary
This online article describes and evaluates the use of risperidone, an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder, as an autism intervention. The article notes that risperidone is sometimes used to treat challenging behaviors in people on the autism spectrum.
The article concludes that there is some evidence to suggest that risperidone is beneficial in the treatment of irritability and hyperactivity in children on the autism spectrum. However, the article also notes that significant side effects may be associated with the use of risperidone. The authors recommend that future research should compare the long-term benefits and risks of using risperidone.
Research Autism was a charity funding research in autism interventions. Research Autism’s information services have been absorbed by the National Autistic Society (NAS). Founded in 1962, the NAS “provide[s] information, support and pioneering services, and campaign[s] for a better world for autistic people. [Website]
Language
English
Subjects
Family Support
Therapies
Publisher
Research Autism
DateModified
9/22/2022 3:23 PM EDT